Semi-solid systems containing azetidine derivatives

Details for Australian Patent Application No. 2004262498 (hide)

Owner Aventis Pharma S.A.

Inventors Cote, Sophie; Peracchia, Maria-Teresa; Bobineau, Valerie

Agent Watermark

Pub. Number AU-B-2004262498

PCT Pub. Number WO2005/013973

Priority 03291796.5 18.07.03 EP

Filing date 8 July 2004

Wipo publication date 17 February 2005

Acceptance publication date 22 January 2009

International Classifications

A61K 31/135 (2006.01) - having aromatic rings, e.g. methadone

A61K 31/397 (2006.01) - having four-membered rings, e.g. azetidine

A61K 47/34 (2006.01) Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives - Macromolecular compounds obtained otherwise than by reactions only involving carbon-to-carbon unsaturated bonds

Event Publications

9 February 2006 PCT application entered the National Phase

  PCT publication WO2005/013973 Priority application(s): WO2005/013973

27 July 2006 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 30 Jun 2006

22 January 2009 Application Accepted

  Published as AU-B-2004262498

21 May 2009 Standard Patent Sealed

3 February 2011 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004262499-Use of spermine and/or spermidine against skin ageting in dietary, pharmaceutical or cosmetic compositions

2004262497-Emulsifying systems containing azetidine derivatives